These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 25475141)
1. Demonstration of extracellular peptidylarginine deiminase (PAD) activity in synovial fluid of patients with rheumatoid arthritis using a novel assay for citrullination of fibrinogen. Damgaard D; Senolt L; Nielsen MF; Pruijn GJ; Nielsen CH Arthritis Res Ther; 2014 Dec; 16(6):498. PubMed ID: 25475141 [TBL] [Abstract][Full Text] [Related]
2. Reduced glutathione as a physiological co-activator in the activation of peptidylarginine deiminase. Damgaard D; Bjørn ME; Steffensen MA; Pruijn GJ; Nielsen CH Arthritis Res Ther; 2016 May; 18(1):102. PubMed ID: 27149996 [TBL] [Abstract][Full Text] [Related]
3. Citrullination of synovial proteins in murine models of rheumatoid arthritis. Vossenaar ER; Nijenhuis S; Helsen MM; van der Heijden A; Senshu T; van den Berg WB; van Venrooij WJ; Joosten LA Arthritis Rheum; 2003 Sep; 48(9):2489-500. PubMed ID: 13130468 [TBL] [Abstract][Full Text] [Related]
5. Increased levels of peptidylarginine deiminase 2 in synovial fluid from anti-CCP-positive rheumatoid arthritis patients: Association with disease activity and inflammatory markers. Damgaard D; Senolt L; Nielsen CH Rheumatology (Oxford); 2016 May; 55(5):918-27. PubMed ID: 26880831 [TBL] [Abstract][Full Text] [Related]
6. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Vossenaar ER; Radstake TR; van der Heijden A; van Mansum MA; Dieteren C; de Rooij DJ; Barrera P; Zendman AJ; van Venrooij WJ Ann Rheum Dis; 2004 Apr; 63(4):373-81. PubMed ID: 15020330 [TBL] [Abstract][Full Text] [Related]
7. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3. Damgaard D; Bawadekar M; Senolt L; Stensballe A; Shelef MA; Nielsen CH PLoS One; 2018; 13(8):e0203214. PubMed ID: 30161253 [TBL] [Abstract][Full Text] [Related]
8. Expanding the citrullinome of synovial fibrinogen from rheumatoid arthritis patients. Sharma M; Damgaard D; Senolt L; Svensson B; Bay-Jensen AC; Nielsen CH; Hägglund P J Proteomics; 2019 Sep; 208():103484. PubMed ID: 31408709 [TBL] [Abstract][Full Text] [Related]
9. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Kinloch A; Lundberg K; Wait R; Wegner N; Lim NH; Zendman AJ; Saxne T; Malmström V; Venables PJ Arthritis Rheum; 2008 Aug; 58(8):2287-95. PubMed ID: 18668562 [TBL] [Abstract][Full Text] [Related]
11. Local administration of glucocorticoids decreases synovial citrullination in rheumatoid arthritis. Makrygiannakis D; Revu S; Engström M; af Klint E; Nicholas AP; Pruijn GJ; Catrina AI Arthritis Res Ther; 2012 Jan; 14(1):R20. PubMed ID: 22284820 [TBL] [Abstract][Full Text] [Related]
12. Rheumatoid arthritis-specific autoantibodies to peptidyl arginine deiminase type 4 inhibit citrullination of fibrinogen. Auger I; Martin M; Balandraud N; Roudier J Arthritis Rheum; 2010 Jan; 62(1):126-31. PubMed ID: 20039406 [TBL] [Abstract][Full Text] [Related]
13. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation. Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029 [TBL] [Abstract][Full Text] [Related]
14. Release of Active Peptidyl Arginine Deiminases by Neutrophils Can Explain Production of Extracellular Citrullinated Autoantigens in Rheumatoid Arthritis Synovial Fluid. Spengler J; Lugonja B; Ytterberg AJ; Zubarev RA; Creese AJ; Pearson MJ; Grant MM; Milward M; Lundberg K; Buckley CD; Filer A; Raza K; Cooper PR; Chapple IL; Scheel-Toellner D Arthritis Rheumatol; 2015 Dec; 67(12):3135-45. PubMed ID: 26245941 [TBL] [Abstract][Full Text] [Related]
15. Novel method to quantify peptidylarginine deiminase activity shows distinct citrullination patterns in rheumatoid and juvenile idiopathic arthritis. Yu K; Dillemans L; Gouwy M; Bessa H; Metzemaekers M; Martens E; Matthys P; Bossuyt X; Verschueren P; Wouters C; De Somer L; Proost P Front Immunol; 2023; 14():1111465. PubMed ID: 36793709 [TBL] [Abstract][Full Text] [Related]
16. Potential protein targets of the peptidylarginine deiminase 2 and peptidylarginine deiminase 4 enzymes in rheumatoid synovial tissue and its possible meaning. Badillo-Soto MA; Rodríguez-Rodríguez M; Pérez-Pérez ME; Daza-Benitez L; Bollain-Y-Goytia JJ; Carrillo-Jiménez MA; Avalos-Díaz E; Herrera-Esparza R Eur J Rheumatol; 2016 Jun; 3(2):44-49. PubMed ID: 27708970 [TBL] [Abstract][Full Text] [Related]
17. Peptidylarginine deiminase expression and activity in PAD2 knock-out and PAD4-low mice. van Beers JJ; Zendman AJ; Raijmakers R; Stammen-Vogelzangs J; Pruijn GJ Biochimie; 2013 Feb; 95(2):299-308. PubMed ID: 23026755 [TBL] [Abstract][Full Text] [Related]
20. Protein Citrullination by Peptidyl Arginine Deiminase/Arginine Deiminase Homologs in Members of the Human Microbiota and Its Recognition by Anti-Citrullinated Protein Antibodies. Pérez-Pérez ME; Nieto-Torres E; Bollain-Y-Goytia JJ; Delgadillo-Ruíz L Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]